NCT05662540View on ClinicalTrials.gov

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 26, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
NK/T-cell Lymphoma
Interventions
DEVICE

Positron Emission Tomography/Magnetic Resonance (PET/MR)

18F-FDG PET/MR imaging (manufacturer: Siemens, model: Biography mMR). Research devices are marketed products.

Trial Locations (1)

200020

RECRUITING

Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER